About CellResearch
CellResearch is a Healthcare company based in Singapore (Singapore) founded in 2002 by Phan Toan Thang. It operates as a stem-cell-based research products and cosmeceuticals are developed. CellResearch has raised $5.9 million across 1 funding round from investors including Cordlife. CellResearch offers products and services including Umbilical Cord Lining Stem Cells, CALECIM®, SOLLAGEN™, Cord Banking, and Contract Research. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Its legal entity is CELLRESEARCH CORPORATION PTE. LTD. Its competitors include Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group and 5 more; 8 of its 10 listed competitors have raised funding.
Company details
CellResearch was founded in 2002 in Singapore within the biotechnology sector. Stem-cell-derived products for research and therapeutic applications are developed, including epithelial and mesenchymal stem cells sourced from cord blood. A cosmeceutical line called Calecim is formulated for skin rejuvenation purposes. Cord blood banking services are provided alongside a global cord registry. Forty patents are maintained for these offerings.
- Headquarters Singapore, Singapore
- Founders Phan Toan Thang
- SectorsHealthcare
- Email••••••••
- Website cellresearchcorp.com
- Social LinkedIn
- Legal Name Cellresearch Corporation Pte. Ltd.
- Annual Revenue$4.06 M (USD)26as on Dec 31, 2021
- Net Profit$980.36 K (USD)-10as on Dec 31, 2021
- Total Equity Funding$5.9M (USD)
in 1 rounds
- Latest Funding Round$5.9M (USD), Series A
Feb 2016
- Investors
Products & Services of CellResearch
CellResearch offers a comprehensive portfolio of products and services, including Umbilical Cord Lining Stem Cells, CALECIM®, SOLLAGEN™, Cord Banking, and Contract Research.
Provides stem cells for research and therapeutic applications.
Offers skincare products derived from stem cell technology.
Delivers solutions for wound healing and resurfacing.
Facilitates storage of cord blood for future medical use.
Conducts research on diseases like diabetes and heart disorders.
Funding Insights of CellResearch
CellResearch has successfully raised a total of $5.9M through 1 strategic funding round. The most recent funding activity was a Series A round of $5.9 million completed in February 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.9M
- Total Rounds 1
- Last Round Series A — $5.9M
- First Round $5.9M
(Feb 2016)
- Investors Count 1
All 1 funding rounds of CellResearch with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2016 | $5.9M | Series A | – | Cordlife | – |
1 investors in total: 1 institutional.
Investors in CellResearch
CellResearch has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Cordlife.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Cordlife is engaged in cord blood banking and diagnostics. | 2001 | cordlife.com | Singapore, Singapore |
Investor details for CellResearch
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of CellResearch
19 people are tracked at CellResearch (11 in leadership, 4 in board & advisors, 4 in team).
| Name | Role | Group |
|---|---|---|
Phan Toan Thang | Co-Founder | Leadership |
Gavin Tan | Founding Director & Group CEO | Leadership |
Fraser Anderson | Associate Director, Corporate Finance | Leadership |
Ivor J Lim | Founding Director & Chief Medical Officer | Leadership |
Xavier Simpson | Chief of Staff | Leadership |
Olivia Sutton | Chief Development Officer, CellResearch Therapeutics | Leadership |
Edwin Chow | Group COO | Leadership |
Paul Binney | Group CFO & Head of Global Distribution | Leadership |
Ong Chee Tian | Technical Director | Leadership |
Nicholas Lang | Chief Commercial Officer & Executive Director, CellResearch Consumer Health | Leadership |
Beatrice Tan | VP, Global Supply Chain & Production | Leadership |
Paul Kemp | Scientific Advisor | Board & advisors |
Wong Keng Lin | Scientific Advisor | Board & advisors |
Andrew Boulton | Scientific Advisor | Board & advisors |
David Armstrong | Scientific Advisor | Board & advisors |
Saravanan Sinniah | Quality Manager | Team |
Jeyakumar Masilamani | Senior Scientific Officer | Team |
Ross Johnstone | Global Trainer | Team |
Audrey Khoo Yt | Laboratory Manager | Team |
Complete people profiles for CellResearch
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of CellResearch
2 dated milestones of CellResearch across 14 years, from founding to its latest funding, stage changes and deals.
- Founded CellResearch is founded.
- Funding First funding round of $5.9M.
Competitors of CellResearch
CellResearch has 10 listed competitors in our database, 8 of them funded. They include Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| straumann.com | 1954 | Basel, Switzerland | – | – | Dental implants and regenerative dentistry products are developed. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| judges.uk.com | 2002 | London, United Kingdom | – | 622 | Acquisition and development of scientific instrument businesses is conducted. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. |
Detailed competitors of CellResearch
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of CellResearch
The website of CellResearch (cellresearchcorp.com) receives about 1K visits a month.
- Monthly visits1K
▼ 16.2% vs previous month
Websites whose visitors overlap most with CellResearch. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| viacellinc.com | 100% | – | – | View details |
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as CellResearch (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cellresearch
Complete news archive for CellResearch
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CellResearch
CellResearch was founded in 2002 and raised its 1st funding round 14 years after it was founded.
CellResearch is headquartered in Singapore, Singapore.
CellResearch is a funded company, having raised a total of $5.9M across 1 funding round to date. The company's 1st funding round was a Series A of $5.9M, raised on Feb 2016.
Annual revenue of CellResearch is $4.06M as on Dec 31, 2021.
CellResearch was founded in 2002 in Singapore within the biotechnology sector. Stem-cell-derived products for research and therapeutic applications are developed, including epithelial and mesenchymal stem cells sourced from cord blood. A cosmeceutical line called Calecim is formulated for skin rejuvenation purposes. Cord blood banking services are provided alongside a global cord registry. Forty patents are maintained for these offerings.
CellResearch's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
CellResearch offers Umbilical Cord Lining Stem Cells, CALECIM®, SOLLAGEN™, Cord Banking, and Contract Research.
CellResearch has 1 investor. Key investors include Cordlife.
CellResearch operates through Cellresearch Corporation Pte. Ltd..